Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$54.36 USD
+1.02 (1.91%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $54.34 -0.02 (-0.04%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: AMC |
6/2024 | $-0.86 | -1.88% |
Earnings Summary
For their last quarter, Crinetics Pharmaceuticals (CRNX) reported earnings of -$0.93 per share, missing the Zacks Consensus Estimate of -$0.84 per share. This reflects a negative earnings surprise of 10.71%. Look out for CRNX's next earnings release on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 8.51%.
Earnings History
Price & Consensus
Zacks News for CRNX
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
CRNX: What are Zacks experts saying now?
Zacks Private Portfolio Services